Epigenomics

provides molecular diagnostic test for the early detection of colorectal cancer...
Read more
Epigenomics CEO: undefined undefined

CEO

- -

CEO Approval Rating

- -/100

1998

PublicAcquisition Pending from New Day Diagnostics LLCFRAEPGNY

8000 NAICS listing
Annual Revenue
$ < 1M
Employees
36
Funding
$110.1M
Acquisitions
1

Epigenomics Competitors

1Rosetta Genomics
2Asuragen
3Biodesix
4ClearPath Diagnostics
5Empire Genomics
6Ambry
7Gene by Gene
8Guardant Health
9Myriad Genetics
10Veracyte

Trending Companies